Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

705 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intraperitoneal Alpha-Radioimmunotherapy of Advanced Ovarian Cancer in Nude Mice Using Different High Specific Activities.
Elgqvist J, Ahlberg D, Andersson H, Jensen H, Johansson BR, Kahu H, Olsson M, Lindegren S. Elgqvist J, et al. World J Oncol. 2010 Jun;1(3):101-110. doi: 10.4021/wjon2010.05.208w. Epub 2010 May 19. World J Oncol. 2010. PMID: 29147189 Free PMC article.
Intraperitoneal alpha-radioimmunotherapy in mice using different specific activities.
Elgqvist J, Andersson H, Haglund E, Jensen H, Kahu H, Lindegren S, Warnhammar E, Hultborn R. Elgqvist J, et al. Cancer Biother Radiopharm. 2009 Aug;24(4):509-13. doi: 10.1089/cbr.2009.0618. Cancer Biother Radiopharm. 2009. PMID: 19694586
Repeated Intraperitoneal alpha-Radioimmunotherapy of Ovarian Cancer in Mice.
Elgqvist J, Andersson H, Jensen H, Kahu H, Lindegren S, Warnhammar E, Hultborn R. Elgqvist J, et al. J Oncol. 2010;2010:394913. doi: 10.1155/2010/394913. Epub 2009 Oct 25. J Oncol. 2010. PMID: 19859581 Free PMC article.
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer Patients.
Cederkrantz E, Andersson H, Bernhardt P, Bäck T, Hultborn R, Jacobsson L, Jensen H, Lindegren S, Ljungberg M, Magnander T, Palm S, Albertsson P. Cederkrantz E, et al. Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):569-76. doi: 10.1016/j.ijrobp.2015.07.005. Epub 2015 Jul 11. Int J Radiat Oncol Biol Phys. 2015. PMID: 26460999
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2.
Elgqvist J, Andersson H, Bernhardt P, Bäck T, Claesson I, Hultborn R, Jensen H, Johansson BR, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L. Elgqvist J, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1228-37. doi: 10.1016/j.ijrobp.2006.07.003. Int J Radiat Oncol Biol Phys. 2006. PMID: 17145538
Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
Elgqvist J, Andersson H, Bäck T, Claesson I, Hultborn R, Jensen H, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L. Elgqvist J, et al. Nucl Med Biol. 2006 Nov;33(8):1065-72. doi: 10.1016/j.nucmedbio.2006.07.009. Epub 2006 Oct 4. Nucl Med Biol. 2006. PMID: 17127181
The percentage of injected activity per gram (%IA/g) for blood, bone and bone marrow all peaked 6 h after injection at 13.80+/-1.34%IA/g, 4.00+/-0.69%IA/g and 8.28+/-1.38%IA/g, respectively. ...
The percentage of injected activity per gram (%IA/g) for blood, bone and bone marrow all peaked 6 h after injection at 13.80+/-1.34%I …
Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose.
Elgqvist J, Andersson H, Bäck T, Claesson I, Hultborn R, Jensen H, Johansson BR, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L. Elgqvist J, et al. J Nucl Med. 2006 Aug;47(8):1342-50. J Nucl Med. 2006. PMID: 16883015
211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T, Andersson H, Divgi CR, Hultborn R, Jensen H, Lindegren S, Palm S, Jacobsson L. Bäck T, et al. J Nucl Med. 2005 Dec;46(12):2061-7. J Nucl Med. 2005. PMID: 16330571
RESULTS: The biodistribution study showed the uptake of the immunoconjugate by the tumor (amount of injected radioactivity per gram) to be 14% after 7 h. At 40 h, the ratio of uptake in tumors to uptake in blood reached a maximum value of 6.2. The administered activ …
RESULTS: The biodistribution study showed the uptake of the immunoconjugate by the tumor (amount of injected radioactivity per gram) to be 1 …
Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L. Elgqvist J, et al. J Nucl Med. 2005 Nov;46(11):1907-15. J Nucl Med. 2005. PMID: 16269606
705 results
Jump to page
Feedback